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1. Introduction
The immune system of vertebrate living beings is a very complicated system that has evolved
a set of mechanisms to get rid of potential pathogens he get in contact with. These mechanisms
are so finely tuned that we don’t even realize how much work our immune defenses are
carrying out each moment to keep us disease free. Unfortunately, as one can figure, the whole
system is not error free.
For example, autoimmune diseases arise when at least one of the mechanisms meant to
preserve tolerance of self breaks. The immune self tolerance is the process by which the immune
system refrain fromattaching the host own body. This is normally the norm but given the huge
complexity of the interdependencies among immune components (cells, molecules, organs,
signals, etc.), and also given that the immune defenses are not static but rather dynamic
and ever changing during our lifetime, it should not be surprising to learn of the different
autoimmune diseases known to date.
Tolerance is the evolutionary result of a multi-layer system whose goal is to weed out
self-reactive cells. Of these mechanisms, lymphocytes T education in the thymus organ
represents the very first one.
In this article we describe a Monte Carlo method to simulate the maturation of key immune
cells. Before describing the algorithm we give a brief introduction of how the immune system
works.
The goal of the present work is purely methodological. In fact, while we focus on
the specific aspect of the examination phase of the T lymphocytes maturation, we use
immuno-informatics data and methods to perform computer simulation of the whole process
without taking into account, for example, the anatomical structure of the thymus organ
where the process of lymphocytes education takes place. Moreover, for reasons that will be
mentioned later, we will specifically deal with CD8+ T-cells (i.e., CTLs) selection rather than
on CD4+ T-cells (T helpers).
1.1 About the immune system
The immune system is the sum of a number of functions exerted at different spatial scales,
from the micro of molecules to the macro of tissues and organs. White blood cells like the
lymphocytes and the phagocytic/dendritic cells are the most important. Their action is to
seek out and destroy disease-causing organisms or substances (generically called antigens)
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like bacteria or virus and to mount a response in terms of production of antibodies or
antigen-specific cells. These are the two types of immune response, respectively humoral
and cytotoxic. Moreover, talking about immunity we have to distinguish between the innate
immunity and the acquired immunity. The first consists of the basic protection mechanisms
like the skin/mucosa barriers and the phagocytic aspecific activity of certain kinds of cells. The
second type of immunity, the adaptive, is the most recent in evolutionary terms, and it is what
confers the immune system its adaptability to new invaders which are in turn the result of
natural selection pressures.
While the cellular components of the innate immunity recognize structures shared by different
classes of microbes, which is as to say that its recognition ability is hard wired into the
membrane receptors, the adaptive immunity consists of a multitude of clones bearing different
cell receptors and therefore able to recognize different antigens. The adaptability of this system
comes from the fact that the immune response elicited by a pathogen is specific: only those
clones able to recognize the antigen will start to proliferate, creating an army of cells with
tailored weapons against that specific antigen.
A crucial step in the recognition of the antigen by the lymphocytes is its presentation by certain
types of cells called antigen presenting cells. These cells capture the antigen, digest it, and then
show, on their membrane surface, bits and pieces of the antigen attached to a molecules called
major histocompatibility complex (MHC). The lymphocytes through their receptors, can only see
the antigen when attached to the MHC.
An important feature of the immune system is its ability to remember already encountered
pathogens. Memory resides in antigen-specific cells that live much longer than normal,
conferring the system the ability to mount a more effective and swift responses the second
time it is threaten by the same pathogen. Memory is the reasons why vaccines can confer
long-lasting protection against infections.
1.2 The diversity of lymphocytes receptors
Without going into detail on the mechanisms of generation of receptor diversity
(combinatorial and junctional diversification), we note that somatic recombination may result
in potentially more than 1015 receptors with different specificities. Given this potential
diversity, it is estimated that only 107 are actually expressed receptors; i.e., different clones
circulating in our body every day.
This enormous diversity of receptors occurs during the maturation process of lymphocytes.
This process starts from bone marrow stem cells and includes three phases: the proliferation
of immature cells, expression of the antigen receptor genes and selection of lymphocytes that
express an antigen receptor useful. Lymphocytes that are present in the immune system are
those who have passed the ripening process. The maturation of T lymphocytes occurs in the
thymus and during this phase are the receptors that will recognize any foreign antigens to the
body. Since the process of gene recombination is random, thymus deletes those cells whose
receptors have high specificity to proteins of the host, while those who are selected will be
able to recognize the MHC molecules of the host. This is crucial because the TCR must also
recognize residues on the MHC molecule in order to make the recognition of an antigen. A
similar process occurs for B cells in bone marrow but mature and not need to recognize MHC
molecules.
1.3 Immune effector mechanisms
There are two types of cell-mediated reactions deputies to remove different types of
intracellular microbes: the first CD4+ T cells activate macrophages so that they destroy
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the microbes contained in their vesicles, the other CD8+ lymphocytes that kill cells
micro-organisms in their cytoplasm, eliminating the reservoir of infection. The humoral
immunity is mediated by antibodies and instead represents the arm of acquired immunity
deputy to neutralize extracellular microbes. Antibodies are molecules of the family of
immunoglobulin. Organism are produced five different classes of Ig that are differentiated
by their heavy chain constant region determines the effector function.
A B lymphocytes activated by antigen recognition may differentiate into a plasma cell or
a cell that produces antibodies. These have the same specific receptor that recognized the
antigen but are able to act remotely as soluble. The antibodies act by using the antigen binding
region to bind to microbes and toxins by blocking the pathological effects, while using the
constant portion of the heavy chain to activate different effector mechanisms that cause the
deletion. Effective action can only be made when several antibodies recognize an antigen and
bind to it.
1.4 The components of the immune system
Lymphocytes are cells with receptors specific for the antigen and are the central component
of acquired immunity. Very similar, the lymphocytes are very heterogeneous in terms of
functional and phenotypic.
B lymphocytes: are the only cells that produce antibodies and mediate humoral immunity.
Express on their surface antibody molecules that serve as receptors for antigen recognition
and to start the activation process. Soluble antigens or bound onto the surface of bacteria or
other cells can bind to these receptors, initiating the humoral response.
T Lymphocytes: mediate cellular immunity. Their receptor recognizes antigen peptides only
fragments linked to protein molecules specialized in presenting antigen (MHC I or MHC II).
The most important T-cells are: or T helper (CD4 + or): Their TCR recognizes peptides bound
to MHC class II. Their function is to help B cells produce antibodies and phagocytes to destroy
microbes incorporated by cytokine release.
Cytotoxic T lymphocytes (CTL or CD8 + or): Their TCR recognizes peptides bound to MHC
class I. Their function is to kill cells infected by intracellular microbes.
Dendritic cells: Although in principle are cells of innate immunity, play their most important
function in presenting antigens to compartment specific immunity. Dendritic cells capture
antigens that penetrate through the epithelium and transport them to draining lymph nodes.
Lymph nodes expose their membrane fragments of microbial protein antigens to activate T
lymphocytes with the specific receptor.
The various cells cooperate to protect the body from infections and illness. They can
communicate through chemical mediators to orchestrate the response; they circulate
throughout the body in the lymphatic and blood system to patrol every single organ.
Lymphocytes are equipped with a transmembrane molecule called receptor that are used to
bind to antigens. This binding event is the first step in recognizing anything dangerous. It is
therefore clear that mother nature has constructed these membrane receptor very carefully.
In fact, if the lymphocytes recognize a self molecule, soon the immune system would start to
destroy it. A self molecule is so called because it belongs to our own body cells, therefore being
the target of an immune attack causes inflammation and damage and leads to autoimmune
disorders.
The causes of autoimmune diseases are unknown, although it appears that in many cases
there is an inherited predisposition to develop them. In a few types of autoimmune disease
(such as rheumatic fever), a bacteria or virus triggers an immune response, and the antibodies
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or T-cells attack normal cells because they have some part of their structure that resembles a
part of the structure of the infecting microorganism.
The membrane receptors of lymphocytes are randomly arranged so, potentially, they can bind
to any molecule. How is then tolerance achieved?
One mechanism is to scrutinize the immature lymphocytes for potentially autoreactive ones
and eliminating them before they go into circulation. For lymphocytes T helpers and cytotoxic
T cells, this step is performed in the organ fromwhich these cells take their name; the thymus.
Thymus education represents the very first method to limit autoreactivity.
1.5 The thymus organ
The functioning of the thymus is far from being fully understood. What is surely known is
that bone marrow-derived T lymphocytes that do not yet express co-receptor (called double
negative DN or CD4−CD8−), enter the thymus, migrate to the thymic cortex (the outer
region) and proliferate. Most of them also begin to express both CD4 and CD8 co-receptors
(double positive DP, or CD4+CD8+) together with the T-cell receptor molecule (TCR) and
its associated accessory proteins (the CDR3 protein complex). At this stage the immature
lymphocytes express high levels of Fas antigen which can trigger death when ligated and
produces very little Bcl-2, a cellular protein that protects against apoptosis. This means that
they are very sensitive to signals that can trigger death by apoptosis. These apoptotic signals
will come from antigen presenting cells (APCs). In particular, in the thymic cortex they interact
with cortical thymic epithelial cells and maturate in single positive (SP) cells (CD4+CD8−
or CD4−CD8+). Then they migrate to the medulla and undergo a series of interaction with
thymic dendritic cells and medullary thymic dendritic cells. This “walk” inside the thymus
lasts for about 2 weeks. Those lucky thymocytes who survive the selection leave the organ to
patrol the body in the search for potential pathogenic agents (Murphy et al., 2008).
The interactions with APCs, who act as “examiners”, is meant to score the cells according
to the ability to recognize the major histocompatbility complex (MHC) molecules (this is
called MHC restriction), and also to the inability to bind peptides that belong to “self” (this
is the tolerance induction). These two requirements are important to guarantee that a matured
T lymphocyte is fully functional and, at the same time that, should he be able to recognize self
molecules, he will not leave the thymus to cause damage.
APCs score T-cells through their T-cell receptor, a membrane protein whose extra cellular
domain is able to bind the MHC-peptide complexes. In contrast to B cells, T-cells cannot
recognize a pathogen on its own since they need to be presented in the context of an
MHC-peptide complex. For most T-cells, the TCR is a heterodimer, composed of an α and a β
chain. There is another δγ based TCR which is seldom encountered. The TCR belongs to the
immunoglobulin superfamily and have oneN-terminal immunoglobulin variable (V) domain,
one constant (C) domain, a transmembrane domain and a short cytoplasmic C terminal
segment. The variable region on the TCR is potentially unique for each T-cell, and is composed
of three parts on both the α and β chains, called complementary determining regions (CDRs).
CDR3 is thought to be the main molecule interacting with the antigen, while CDR2 would be
interacting with the MHCmolecule. It is important to note that TCRs originate from a limited
number of genes (65 V genes, 27 D genes, 6 J genes), but despite this, the immune system is
able to engender a great number of receptors (Goldsby et al., 2000; Murphy et al., 2008).
The generation of the TCR is similar to the one of immunoglobulins (BCR) in B cells. The α
chain is generated by VJ recombination while the β chain relies on V(D)J recombination. The
gene segments are then randomly joined together to produce the final TCR. The CDR3 region
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corresponds to the junction of the V and J segment on the α chain and the V D and J β chain,
explaining its high variability and its role in antigen binding thereof.
The TCR selection in a primary organ like the thymus is called central tolerance induction and
is the first mechanism to assure that most auto-reactive cells are eliminated. Fortunately is
not the only one. In fact, since this mechanism is not hundred percent efficient, the immune
system is equipped with other mechanisms that constitute the peripheral tolerance and induce
cell death in auto-reactive lymphocytes. If this does not happen, then autoimmune diseases
arise.
Understanding the complex machinery of how thymic selection imparts MHC-self-peptide
complex restriction and at the same time a high degree of self tolerance on the T-cell repertoire
is a very challenging task and a lot of aspects remains unclear (Klein et al., 2009).
1.6 A short review of mathematical models of T-cell development
Fewmathematical models have been used to study specific issues of T-cell development. Most
of these models are based on ordinary differential equations. For example, one of the first
mathematical model to study thymocyte subset dynamics was introduced in (Mehr et al.,
1995). In this model the equations define time evolution of thymocyte subsets, including DN,
DP, CD4SP, and CD8SP cells. The model predict that negative selection likely operates at the
DP stage or later. Moreover the model revealed that the CD4SP over CD8SP cell ratio fits the
“instructive” theory of thymic lineage commitment (Germain, 2002; von Boehmer & Kisielow,
1993). In (Mehr et al., 1997) the idea that thymocytopoiesis may be subject to feedback
regulation by mature lymphocytes is proposed and experimental data was analyzed using
mathematical models. Another equation-based model was used to to compare the intrathymic
development of bone marrow precursors, derived either from young or old donors (Mehr
et al., 1993). In Mehr et al. (1998) the phenomenon of MHC-linked syngeneic developmental
preference was analyzed by amathematical model. In another study, the authors focused on the
naïve T-cell compartment defined by the presence of T-cell receptors excision circles formed
during T-cell receptor gene rearrangement (Hazenberg et al., 2000).
In contrast to the above mentioned studies, the model introduced in (Efroni et al., 2005)
takes into account the spatial information in thymocyte development, by using agent-based
modeling. This modeling paradigm is ideal for uniquely identify cellular characteristics,
like for example, receptor expression, to distinguish the different stages of the cell cycle
in specific anatomical compartments (Efroni et al., 2007; 2003). Another example of a
discrete spatial model can be found in (Souza-e Silva et al., 2009). In this study a cellular
automaton was constructed to describe thymocyte migration and development in the thymic
microenvironment.
The model presented in the present article takes yet another approach. We simulate MHC
restriction and tolerance induction by a stochastic model that includes bioinformatics methods
to assess the affinity between a cell receptor and an MHC molecule bound to a self peptide.
This study follows the lines of Morpurgo et al. ((Morpurgo et al., 1995)) but diverges from it
in that the molecules represented (i.e., TCRs, MHCs and self peptides) are not strings of zeros
and ones (i.e., binary strings) but rather strings of letters representing the twenty amino acids.
Moreover, most importantly, the function used to compute the affinity among these molecules
is provided by data-driven machine learning bioinformatics methods.
In immunology what is of outmost importance is to “predict” whose part of the antigenic
molecule will constitute an immunogenic epitope. Broadly speaking there are two ways of
doing it. The first is to simulate the chemical-physical interactions between peptides and
135A Monte Carlo Simulation for the Construction of Cytotoxic T Lymphocytes Repertoire
www.intechopen.com
MHC molecules (e.g., NAMD, NAnoscale Molecular Dynamics or ABF, Adaptive Biasing
Force software (Darve & Pohorille, 2001)), that takes hours to simulate a single peptide-MHC
interaction what in reality lasts fractions of a second. The second possibility is to resort to
bioinfomatics approaches that use machine learning and statistical methods to extract and
generalize information from available experimental data of MHC-peptide sequences (for a
review see e.g., (Lundegaard et al., 2007)). These methods take a fraction of a second to run on
common workstations hence, from this point of view, are preferable to the first one.
Immunoinformatics is a new discipline emerging from the growing knowledge gathered for
decades in experimental immunology and immunogenomics (Korber et al., 2006; Petrovsky &
Brusic, 2002). Being both an experimental and theoretical field, it is foreseen that immunomics
will play an important role for the future of immunology (Petrovsky & Brusic, 2006).
The goal of the present work is to use machine learning techniques for molecular-level
predictions of major histocompatibility complex-peptide binding interactions (Lund et al.,
2004; Nielsen et al., 2007; 2004), and a more general protein-protein potential estimation
(Miyazawa & Jernigan, 1999) to perform Monte Carlo simulation of the selection of
thymocytes in the thymus.
MHC class I binding predictions methods based on machine learning have increased their
accuracy over the years, thus leading to reliable predictions. The same level of predicting
power has not yet been reached by class II prediction methods (Lin, Ray, Tongchusak,
Reinherz & Brusic, 2008; Lin, Zhang, Tongchusak, Reinherz & Brusic, 2008). This is thought
to be partly due to the structure of the MHC molecules, which binding pockets are open in
class II, thus allowing peptides of different length to bind to the groove. In contrast, class I
molecules restrict the size of the peptides they bind to to 8-12 amino-acids (Yewdell et al.,
2003; 1999), with an average length of 9 amino-acids. Therefore for convenience we restrict
the attention to the education of CD8+ T-cells rather than on CD4 T-cells (Lund et al., 2005).
2. The construction of the T-lymphocytes repertoire: a Monte Carlo method
The thymus organ is modeled as a simple two-stage filter. In the first stage, APCs give a
survival signal to immature T-cell if a binding to the MHC-peptide complex occurs but
“weakly”, i.e., no binding will drive the cell to apoptosis; in the second stage the survival
signal is given if the affinity to MHC-peptides presented by APCs is not “too high”, i.e., high
avidity for self peptides drives the cell to apoptosis (see left panel of figure 1).
In real life, bone marrow-derived T-cells entering the thymus initially home in the thymus
cortex where they start to proliferate. Shortly after, rearrangement of the gene segments that
encode the α and β chain of the T-cell receptor begins. Somatic rearrangementmakes the TCRs
highly diverse (about 108 (Arstila et al., 1999)).
All we need to account in the simulation is this huge variety. We do it by assigning random
amino acid string receptors to each lymphocyte. Since the complementarity-determining
region (CDR) of TCRs is what interacts directly with antigenic peptides bound to grooves
of MHC molecules, the amino acid string we define for each T-cell is meant to represent not
the whole TCR but rather its CDR.
The choice for the length of this string, thus the size of the repertoire, is not an easy one.
Studies of various T-cell subsets from humans in physiological and pathological conditions
have found an average length between 6 and 60 bases with a high variability in the different
groups but only for the CDR3 suggesting that the whole CDR is much longer (Nishio et al.,
2004). However not all arrangements of the genes gives a functional TCR and therefore for the
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Fig. 1. The two-layer filter realized by the thymus to eliminate auto-reactive T lymphocytes.
T-cells develop self tolerance during negative selection, whereas they are “discarded” as
useless during positive selection.
sake of simplicity we decide to use only 8+12=20 letter to represent respectively the CDR of
the α and of the β region of the T-cell receptor.
Self antigens are molecules, products of the organism own cells and as such tolerated by the
parent immune system.We represent self molecules as amino acid strings. The question is how
long. As we mentioned earlier, the prediction of class I MHC peptides is more accurate than
those of class II (Lund et al., 2005). The reason for this is that in contrast to class II MHC that
has the ends of the groove open, those of class I MHC are closed so a protein fragment to fit
in properly must be about nine amino acid in length. In other words, class I-type epitopes are
linear sequences of 8 to 11 amino acids that are processed from any protein of the pathogen.
However each MHC class I molecule (whose total number surpasses the thousands of alleles
to date (Nielsen et al., 2007)), is characterized by a specific binding motif that is possible
to “decode”. For the vast majority, the motif length is nine amino acids long, therefore by
restricting our study to CTL’s tolerance induction, we can define “self” any string of nine
amino acids.
To be presented by the APCs, the peptide has to attach to the MHCmolecule and therefore we
need a method to predict peptide binding to class I MHC.
2.1 Identifying peptides for class I MHC
Methods for class I T-cell epitope prediction rely mainly on machine learning techniques
(Lund et al., 2004; Nielsen et al., 2004). In particular neural networks seems to perform
well. For example the authors in (Nielsen et al., 2003) show that neural networks trained
to predict binding versus non-binding peptides, are superior to other methods (Lin, Ray,
Tongchusak, Reinherz & Brusic, 2008; Lin, Zhang, Tongchusak, Reinherz & Brusic, 2008).
Furthermore, quantitative neural networks allow the straightforward application of a query by
committee (QBC) principle, in which particularly information-rich peptides can be identified
and subsequently tested experimentally. Moreover, iterative training based on QBC-selected
peptides considerably increases the sensitivity of the prediction without compromising its
efficiency (Buus et al., 2003).
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The Monte Carlo method described herein does not make a direct use of neural network but
rather employs a derived Position Specific Scoring Matrix (PSSM)-based method. In practice, for
each MHC allele we use the binding motif matrices generated from the neural network methods
as described in (Nielsen et al., 2007). In short, first the neural network is used to rank a set of
106 randomly selected natural peptides from the human genome, then the top one percent of
the peptides are flagged as binders and used to generate a binding motif, that is a 9 by 20
matrix. These matrices (one for each MHC) are calculated using sequence weights, and are
corrected for low counts (Altschul et al., 1997; Nielsen et al., 2004).
Binding motifs matrices are made of propensities calculated as 2 log2(p/q), where p is the
probability of finding a given amino acid at a given position, and q is the probability of finding
that amino acid in any protein in general. These propensities are computed for each of the nine
positions on a potential epitope, and give the propensity for each of the 20 amino acids.
Furthermore, we set an allele-specific threshold ΘH as the average score of the low-scoring
binders in the top one percent of the binders (see (Nielsen et al., 2003; Yewdell et al., 1999) for
details).
Finally, having the PSSM and its corresponding threshold ΘH, we can discriminate binders
and non binders by calculating the score and comparing it with ΘH. More formally, let Ω
be the set of amino acid symbols Ω and p = [a1, a2, . . . , al(a)], represent a contiguous stretch
of amino acids, with l(p) the length of the sequence and ai ∈ Ω the ith amino acid in the
sequence. For a given 9-mer p = [a1, a2, . . . , a9], the sum of the values at each position in the
scoring matrix H = {hai,i}i=1,...,9,ai∈Ω, of a particular MHC gives the propensity to bind that
MHC, i.e.,
p is a peptide ⇐⇒
9
∑
i=1
hai,i ≥ ΘH. (1)
Therefore of all possible 9-mers only those for which ∑9i=1 hai,i ≥ ΘH , where ΘH is the
allele-specific threshold, are considered epitopes that can be presented by antigen processing
cells.
The second thing we need is to have a way to assess whether a TCR interacts with a given
MHC-peptide complex or not.
2.2 Interaction with antigen presenting cells
To date, there is no general method that can be used to predict if, for example, a TCR
will interact with any given MHC-peptide complex. For this reason we resorted to the
Miyazawa-Jernigan residue-residue potential (Miyazawa & Jernigan, 1996) to score the
strength of the interaction. The work performed by Miyazawa and Jernigan on protein energy
potentials (Miyazawa & Jernigan, 2000) provides us with a method for assessing the chances
of direct interactions among proteins in the simulation. The protein-protein potential concept
was derived from the analysis of 3D structures in which the relative position of amino acids
were determined. The contact potential matrix estimated by Miyazawa and Jernigan reflects
the entropy between two residues; a low entropy means that the pair of residues has low
energy and therefore that interaction is possible.
For CD8+ T-cell recognition, the procedure to compute the binding score requires the
definition of class I MHC specific contact matrices. These matrices can be computed by looking
at known protein 3D structures found in the Protein Data Bank (PDB, www.pdb.org). In the
end, we decided to adopt just oneMHC contact matrix for all class I alleles. The reason for this
is twofold: i) we did not find too much differences among contact matrices of different alleles
and ii) the one we decide to use has been calculated from the best resolution data (i.e., 1.4 Å).
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This contact matrix (that we call C) was calculated taking residues that i) are within a distance
of 5 Å and, ii) show contacts between the MHC-epitope complex and the two chains (heavy
and light) of a bound TCR.
The distance of 5 Å was selected because most crystal structures with experimentally verified
B cell epitopes show that the residues on the antibody in contact with an epitope lie within
a 5 Å radius. Again the reason for looking at B cell epitopes is twofold: firstly TCRs and
immunoglobulins are not that different, and secondly, there are a lotmore antigen Ig structures
than MHC-pep-TCR structures.
We extend the use of this value to the minimum distance needed between residues for
molecular interaction. By using the solved structures, it is possible to determine which residue
on a TCR binds to the MHC or to the peptide. The contact matrix derived for class I binding
that we use in the simulation is shown in the right panel of figure 1.
Similarly, one determines the residues that are generally in contact with the TCR. These are
what we call MHC pseudo-sequences (indicated with MHC). Again, the contact residues are
defined as being within 5.0 Å of the peptide in any of a representative set of HLA-A and
-B structures with 9-mer peptides and TCRs (Nielsen et al., 2007).
The contact potential defined between a TCR and an MHC-peptide complex is thus based
on the Miyazawa-Jernigan score as follows. Let {Ma,b}a,b∈Ω, be the matrix in (Miyazawa
& Jernigan, 2000), x = [x1, . . . , xl(x)] a TCR, y = [y1, . . . , yl(y)] a MHC-peptide complex
composed by the pseudo sequence of the MHC and the peptide molecules, and C the contact
matrix. We first compute the binding affinity between x and y as
Mˆ(x, y) =
l(x)
∑
j=1
l(y)
∑
k=1
(Mxj ,yk · Cj,k).
Then, since we need to define a probability, this value is normalized and further compared to
a threshold value
M(x, y) =
{
Mˆ(x,y)−µMˆ
k·σMˆ
if (Mˆ(x, y)− µMˆ)/(k · σMˆ) ≥ P95,
0 otherwise
(2)
where µMˆ and σMˆ are respectively the average and the standard deviation that have been
previously estimated, k is a free parameter chosen to have M(x, y) ≤ 1, and P95 is, the 95th
percentile rank of the estimated distribution. Finally, we use the binding affinity M(x, y) of
eq(2) as the probability of the binding between x and y.
2.3 Positive selection of TCRs
Given nmhc major histocompatibility complex molecules, we calculate the probability to pass
the positive selection of a cell bearing a random TCR as follows
Pr+ = 1−
nmhc
∏
j=1
(1− M(TCR, MHCj⋆)), (3)
where M(·, ·) is the Miyazawa-Jernigan contact potential in eq(2), and MHC⋆ indicates that only
residues of the TCR in contact with the MHC are taken into account (the wildcard ⋆ means
that no matter what the peptide is, we givemoreweight to the MHC rather than to the peptide
by summing a low constant value for each residue).
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2.4 Negative selection of TCRs
If the cell survives the previous step with probability given by equation 3, then it can be
negatively selected with probability
Pr− =
[ nmhc
∏
j=1
nself
∏
k=1
(1− M(TCR, MHCjselfk))
]E (4)
where the MHCjselfk is a string composed by the pseudo sequence MHCj and the chosen
peptide selfk. The parameter E represents the efficiency in the selection process: higher
efficiency means better filtering, that is, less self-reactive cells will slip out the thymus. From
the point of view of the calculation of the survival rate of the immature cells entering the
thymus, the negative selection is treated as if the thymus were composed by E sub-layers
simulating as many encounters with each thymic cell receptor specificity because of the
crowded nature of the thymus.
Equation 4 gives the probability that the TCR does not matches any of the self molecules with
any of the MHCs.
Finally, we allow the T-cell to leave the thymus and to reach a secondary organ as a mature
thymocyte with a probability given by the product of the probability of being positively
selected and the probability of being negatively selected,
Pr(TCR is selected) = Pr+ · Pr−.
The whole algorithm is summarized as pseudo-code in figure 2.
3. The outcome
Figure 3 shows the Logo plots of the TRC sets that have been filtered in during the thymus
selection, that is, those bear by cells leaving the thymus as operational CTLs. The height of the
letters reflects the Shannon information at individual positions.
In figure 3 it can be observed that there are specific preferential positions for some amino acids
(i.e., smaller entropy of amino acid distributions in Logo plots). The analysis of these positions
reveals a smaller entropy (i.e., higher bars) which is consistent with the contact matrix shown
in the right panel of figure 1; the more contact positions on the TCR, the less the degrees of
freedom.
Interestingly, positions 13 and 19 have respectively no interaction (position 13) or just one
interaction (position 19) with the peptide (see right panel of figure 1). This means that negative
selection does not influence the amino acid distributions for these positions in figure 3,
resulting in similar conservation rates. In contrast, position 16 strongly interacts with both
MHC (4 contacts) and peptide (3 contacts) so that it provides a strong constraint on the
corresponding TCR residues, resulting in a smaller bar of the Logo plot because of a lack of
match. Summarizing, the positive selection step sets a strong constraint to TCR sequences
whereas the effect of negative selection provides one more constraint to the sequences at
position 16.
Once we have selected the TCRs, tcr1, . . . , tcrN by executing the algorithm described in
figure 2, we can compute the average auto-reactivity as the average of the probability to
recognize at least one self peptide attached to one MHC molecule: α = 1N ∑
N
i
(
1− Pr−
)
.
This value depends on the parameters chosen; for example it depends on E and on the
MHC1, . . . , MHCnmhc . It also depends on the self molecules self1, . . . , selfnself . However, for nself
large enough, the actual amino acid strings are less important their number nself itself. This
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input(E, N, nmhc); input parameters
for (i = 1; i≤ nmhc ; i++) {
read(Hi); read the MHC specific matrix
read(MHCi); read the MHC pseudo sequence
read(ΘHi ); read the MHC specific threshold
}
input(nself); input the number of self molecules
i == 1;
while i ≤ nself { randomly choose nself 9-mers
pi = random(); pick randomly a self peptide
if ( ∃k : binds(Hk, pi) == true) { if it binds at least one MHCmolecule than accept it
Sel f ← pi; pi will be shown as self
i++;
}
}
i=1;
while i ≤ N { select TCRs
TCRi = random(); generate a random amino acid string for TCR
Pr+ = compute(TCRi); compute Pr+ as in equation 3
Pr− = compute(TCRi); compute Pr− as in equation 4
if (rand(0,1)<Pr+ · Pr−){
Selected ← TCRi; TCR passes the thymus selection
i++;
fi
}
output(Selected = TCR1, . . . , TCRN); TCRs that leave the thymus
Fig. 2. We randomly select nself 9-mers that bind at least one of the nmhc MHC molecules.
Then we generate a random TCR and calculate the probability of being positively selected
and those of being negatively selected. We iterate until we stochastically have N TCRs.
dependence is shown in figure 4. As expected, increasing the thymic efficiency E the average
self reactivity α decreases. On the other hand for large values of E, α is less influenced by the
number of self peptides nself.
The number of self peptides nself therefore does not dramatically influence α but it does
determine the probability for a T-cell to pass the selection instead. In other words it is related
to the fraction of cells that leave the thymus. It has been estimated that each day of a young
person 60× 106 immature cells are tested but only 1 to 3% exit the thymus (Goldsby et al.,
2000; Murphy et al., 2008). Figure 5 shows the ratio between the number of cells exiting the
thymus (“out”) and those entering the thymus (“in”) against the number of self peptides
nself. The figure shows that we can get reasonable out/in ratios with a number of self
peptides between 100 and 200. Each point is the average of hundreds of independent runs
with a randomly chosen set of self peptides. Note however that in general this curve depends
on other parameters (E) and therefore is not too indicative of the real number nself of self
peptides.
An interesting question that has been already investigated long time agowith a computational
model ((Celada & Seiden, 1992)) is to calculate the “optimal” number of MHC molecules.
We performed similar experiments varying the number of MHC molecules and computing
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Fig. 3. Logo plots of the TRC sets that leave the thymus as operational CTLs TCRs. The height
of the letters reflects the Shannon information at individual positions. Parameters nself = 100
and E = 10. The MHC set is A*0201, A*6841, B*5304, B*5309. The Logo plots have been
calculated using a small sample (i.e., 100) of the population of TCRs passing the selection.
Fig. 4. Auto-reactivity rate α(E, nself) of the selected cells (those leaving the thymus) with
respect to E and nself. Higher E corresponds to less average auto-reactivity. The influence of
nself is only marginal. The MHC alleles used are those reported in the caption of figure 3.
the average self reactivity α(nmhc) of the selected TCRs. What we found is interesting though
incorrect. In fact, the minimum of the self reactivity is attained for nmhc = 8 which is close to
the real value of 6 alleles (figure 6). The overall curve is however in line with the ambivalent
role of the MHCs: on the one hand, more MHCs foster the presentation of self peptides and,
on the other hand, it limits the T-cell repertoire in the negative selection. An optimal number
is therefore expected as the combination of the two opposed effects.
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Fig. 5. The ratio between the number of cells entering the thymus (“in”) and those leaving the
thymus (“out”) plotted against the number of self peptides nself. Parameter E = 10.
MHC-related parameters as in caption of figure 3. Parameters E=60, nself=100.
Fig. 6. This plot shows the average self-reactivity as a function of nmhc. Parameters E=60,
nself=100.
4. Conclusions
We have described a Monte Carlo simulation of the thymus where CTLs are selected on
the basis of the affinity of their TCRs to MHC molecules and self peptides. We have used
data-driven prediction tools to identify suitable self peptides for a specific MHC set of
molecules. Furthermore, we have defined a general protein-protein binding potential on the
basis of the work of Miyazawa and Jernigan on protein energy potentials (Miyazawa &
Jernigan, 2000) that provides a method for assessing the chances of direct interactions among
proteins.
Finally, the binding affinity between the TCR and the MHC-peptide complex is computed by
taking into account a MHC class I specific contact matrix. This matrix was derived by finding
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residues in contact between the α and β chains of the TCR and the HLA-A2 heavy chain of
an MHC molecule in a high resolution 3D structure (access number 1OGA for Protein Data
Bank).
By running a large number of simulations we have estimated the average auto-reactivity rate
for a wide range of the parameters and found that auto-reactive cells are able to leave the
thymus but their number and their overall ability to recognize self peptides decreases with E,
a parameter that indicates the “time” spent in the thymus. However this rate is only slightly
affected by the number of self peptide presented nself.
Other simulation performed changing the number of MHC alleles nmhc resulted in a minimum
of average self-reactivity for nmhc = 8 which is wrong but not too distant from reality.
Take together, these results show that the simulation performs reasonably well. This is
encouraging given the number of working assumptions that we had to make at this stage.
This study follows the lines of Morpurgo et al. ((Morpurgo et al., 1995)) but diverges
from it in that the molecules represented are not binary strings but rather sequences
of amino acids and, most importantly, the function used to compute the affinity among
these molecules is provided by data-driven machine learning bioinformatics methods. We
have already adopted this approach in a previous (Rapin et al., 2010); we believe that,
although preliminary and somehow approximate at this stage, it provides a promising way
to incorporate immuno-informatics resources (both data and methods) to systemic level
stochastic simulations of immunological processes.
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